• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ocera Therapeutics Inc

+ Add to Watchlist

OCRX:US

5.5100 USD 0.0300 0.54%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Ocera Therapeutics Inc (OCRX)

Open: 5.4600 Day's Range: 5.3300 - 5.5100 Volume: 23,182
Previous Close: 5.5400 52wk Range: 5.2580 - 19.9400 1-Yr Rtn: -36.74%

Stock Chart for OCRX

No chart data available.
  • OCRX:US 5.5100
  • 1D
  • 1M
  • 1Y
5.5400
Interactive OCRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OCRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8234
Est. EPS (USD) (12/2014) -1.9550
Est. PEG Ratio -
Market Cap (M USD) 108.78
Shares Outstanding (M) 19.74
30 Day Average Volume 27,542
Price/Book (mrq) 2.3465
Price/Sale (ttm) 186.5254
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OCRX

Ocera Therapeutics, Inc. develops novel therapeutics products. The Company's products are designed to treat liver and gastrointestinal diseases.

Linda S GraisPresident/CEOSharon E TetlowActing CFO/Treasurer
Rajiv PatniChief Development OfficerFranck S RousseauChief Medical & Dev Officer
More Company Profile & Key Executives for OCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil